HEALINE

Weekly Summary -- March 29, 2019

Friday, Mar. 29, 2019 (Pharmacist's Briefing) -- Here are what Pharmacist's Briefing editors consider the most important developments for the week of March 29, 2019

U.S. Flu Season Ebbing, but Cases Still Widespread: CDC

FRIDAY, March 29, 2019 (Pharmacist's Briefing) -- Though flu season has probably peaked, beware: Influenza is still widespread in much of the United States, federal health officials said Friday.

Read More

Spring Is the Sneezing Season

FRIDAY, March 29, 2019 (Pharmacist's Briefing) -- Spring is in the air, and that can mean misery for people with seasonal allergies.

Read More

Climate Change Will Aid Spread of Disease-Bearing Mosquitoes

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- You thought Zika was scary? Well, get this: Global warming places up to 1 billion people worldwide at risk of exposure to disease-carrying mosquitoes over the next 50 years, new research indicates.

Read More

In Most States, Insurance Won't Cover Addiction Treatments

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- In a finding that brings bad news as America struggles with an opioid epidemic, a new report shows that only four states provide adequate insurance coverage for addiction treatment.

Read More

Brain Stimulation May Soothe Severe Depression

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- For those who suffer debilitating depression, stimulating the brain can bring desperately needed relief, new research shows.

Read More

Common MS Treatment Can Bring Longer, Healthier Life

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- An older but still common multiple sclerosis (MS) treatment has an unexpected perk: It not only quells symptoms, but patients may also live longer.

Read More

Heart Failure Hospitalizations Spike When Flu Season Peaks

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- Weakened hearts grow weaker and fail when influenza rages throughout the land, a new study reports.

Read More

Opioid Overuse Can Lower Hormones to Harmful Levels

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- Add one more issue to the growing list of harms from opioid abuse: Long-term use may lead to hormone deficiencies that affect a man's health.

Read More

Bad Info May Be Scaring Patients Away From Heart-Healthy Statins

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- More than a quarter of people who could benefit from taking statins don't, and a new survey suggests that while not enough doctors are prescribing the cholesterol-lowering drugs, fears about side effects also play a part.

Read More

For One Woman, Popular Red Yeast Supplement Brought on Liver Damage

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- She thought red yeast supplements would be a natural way to lower her cholesterol. What could be easier?

Read More

Common Diabetes Test May Often Miss the Mark

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- A commonly used diabetes test may not spot the disease as well as an older test does, a new study suggests.

Read More

Colorado Sees Spike in ER Visits After Pot Made Legal

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- If Colorado is any indication, the legalization of marijuana comes with a downside.

Read More

'Male Pill' Makes Another Advance

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- A male contraceptive pill, long a goal of men -- and women -- everywhere, may be one step closer to reality, U.S. researchers report.

Read More

Simple Rapid Urine Test Can Help Diagnose Preeclampsia

FRIDAY, March 29, 2019 (Pharmacist's Briefing) -- A simple point-of-care urine test can rapidly detect preeclampsia, according to a study published in the February issue of EClinicalMedicine.

Read More

Dietary Fatty Acid Intake Linked to Pediatric Asthma Morbidity

FRIDAY, March 29, 2019 (Pharmacist's Briefing) -- Intake of omega-3 and omega-6 is associated with pediatric asthma morbidity and may modify the response to indoor particulate matter (PM), according to a study published online March 29 in the American Journal of Respiratory and Critical Care Medicine.

Read More

Lifetime HTN Risk High for Black Men and Women, White Men

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- Lifetime risks of hypertension under the American Heart Association (AHA) and American College of Cardiology (ACC) 2017 threshold exceed 75 percent for white men and African-American men and women, according to a study published online March 27 in JAMA Cardiology.

Read More

Guidance Lists New First-Line Treatment for Severe Malaria in the U.S.

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- The drug artesunate -- the World Health Organization-recommended first-line treatment for severe malaria -- will become the first-line treatment for severe malaria in the United States, the U.S. Centers for Disease Control and Prevention says in a new guidance to health care providers.

Read More

Drug Survival Rates Highest for Ustekinumab for Pediatric Psoriasis

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- In real-life conditions, drug survival rates are higher for ustekinumab than for adalimumab and etanercept for all treatments and types of psoriasis in children, according to a study published online March 18 in the Journal of the European Academy of Dermatology and Venereology.

Read More

FDA: Breast Density Must Be Reported to Women During Mammograms

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- Women with dense breasts who get mammograms must be told of their higher risk for breast cancer under new rules proposed Wednesday by the U.S. Food and Drug Administration.

Read More

User Data From Medicine-Related Apps Routinely Shared

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- User data from medicine-related apps are routinely shared, according to a study published online March 20 in The BMJ.

Read More

FDA Panel: Too Early to Ban Breast Implant Linked With Cancer

TUESDAY, March 26, 2019 (Pharmacist's Briefing) -- It is too early to ban a type of breast implant recently linked to a rare form of cancer, a U.S. Food and Drug Administration expert panel advised Monday.

Read More

Guidance Provided for Managing Diabetes in Seniors

TUESDAY, March 26, 2019 (Pharmacist's Briefing) -- Recommendations have been developed for the management of diabetes in older adults; the clinical practice guideline was published online March 23 in the Journal of Clinical Endocrinology & Metabolism to coincide with the annual meeting of The Endocrine Society, held from March 23 to 26 in New Orleans.

Read More

Ocular Protein Levels May Be Useful for Alzheimer Testing

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- Patients with poor cognitive function have significantly lower levels of Alzheimer disease-related biomarkers in the vitreous humor, according to a study published March 8 in the Journal of Alzheimer's Disease.

Read More

HBV, HCV Control Aids Kidney Transplant Outcomes

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- The outcomes of kidney transplants in patients with viral suppression are as good as those for kidney transplants in patients not infected with hepatitis B virus (HBV) or hepatitis C virus (HCV), according to a study published online March 14 in the Journal of Hepatology.

Read More

Use of Biologics to Treat IBD in U.S. Adults May Be Suboptimal

FRIDAY, March 29, 2019 (Pharmacist's Briefing) -- Varied study design and methodology make it difficult to assess real-world trends in adherence and persistence in use of biologics among U.S. adults with inflammatory bowel disease (IBD), according to a review published online March 14 in the Journal of Clinical Pharmacy and Therapeutics.

Read More

Docetaxel Chemo Ups Survival in High-Risk Localized Prostate Cancer

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- Adding docetaxel-based chemotherapy (CT) to standard treatment for high-risk nonmetastatic prostate cancer improves survival, according to a study published online March 12 in the Journal of Clinical Oncology.

Read More

FDA Grants Approval for Hypogonadism Treatment

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- Jatenzo (testosterone undecanoate), an oral testosterone capsule, has been approved to treat men with certain forms of hypogonadism, the U.S. Food and Drug Administration announced Wednesday.

Read More

Contact Lens-Based Antihistamine Delivery Effective

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- A contact lens (CL)-based drug delivery system is effective for therapeutic delivery of the antihistamine ketotifen, according to a study published online March 19 in Cornea.

Read More

FDA Approves Mayzent for Relapsing Multiple Sclerosis

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- Mayzent (siponimod) pills have been approved by the U.S. Food and Drug Administration for adults with relapsing multiple sclerosis.

Read More

Tx Adherence for Inflammatory Bowel Dz Lower in the Educated

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- Nonadherence to inflammatory bowel disease (IBD) treatment is more common among wealthier, more educated patients, according to a study published online March 18 in JGH Open.

Read More

Taxane + Platinum Feasible for Adjuvant Tx in Endometrial Cancer

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- Taxane plus platinum regimens may be a reasonable alternative to doxorubicin plus cisplatin as postoperative adjuvant chemotherapy for endometrial cancer that carries a high risk for progression, according to a study published online March 21 in JAMA Oncology.

Read More

Statins Cut Risk for Major Vascular Events in Older Patients

TUESDAY, March 26, 2019 (Pharmacist's Briefing) -- Statins reduce the rate of vascular events regardless of patient age, according to a meta-analysis recently published in The Lancet.

Read More

Levothyroxine Does Not Up Fertility in Women With TPO Ab

TUESDAY, March 26, 2019 (Pharmacist's Briefing) -- For euthyroid women with thyroid peroxidase antibodies and a history of miscarriage or infertility, levothyroxine does not result in an increased rate of live births versus placebo, according to a study published online March 23 in the New England Journal of Medicine to coincide with presentation at the annual meeting of The Endocrine Society, held from March 23 to 26 in New Orleans.

Read More

Radiomic Features May Predict Response to Chemo in NSCLC

TUESDAY, March 26, 2019 (Pharmacist's Briefing) -- For patients with lung adenocarcinoma, radiomic texture features extracted from within and around the nodule on baseline computed tomography (CT) scans can predict response to chemotherapy, according to a study published online March 20 in Radiology: Artificial Intelligence.

Read More

Topical Immunotx for Actinic Keratosis May Prevent Cancer

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- A short course of calcipotriol plus 5-fluorouracil (5-FU) treatment for actinic keratosis (AK) is associated with induction of robust T cell immunity and reduced development of squamous cell carcinoma (SCC) within three years, according to a study published in the March 21 issue of JCI Insight.

Read More

Older T1DM Patients Often Unaware of Hypoglycemic Status

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- Older adults with type 1 diabetes mellitus (T1D) spend more than an hour per day in the hypoglycemic range, according to a study presented at the annual meeting of The Endocrine Society, held from March 23 to 26 in New Orleans.

Read More

Special Bag Helps Patients Get Rid of Unused Opioids

FRIDAY, March 29, 2019 (Pharmacist's Briefing) -- After undergoing surgery, many people who are prescribed opioid painkillers have no idea how to dispose of leftover pills so they won't be misused by others or harm the environment.

Read More

Long-Term Phentermine Use Safe, Effective for Weight Loss

FRIDAY, March 29, 2019 (Pharmacist's Briefing) -- Patients taking phentermine for weight loss for more than three months experience greater weight loss without an increased risk for incident cardiovascular disease or death, according to a study published online March 21 in Obesity.

Read More

Receiving Activated Charcoal Bag Tied to Proper Opioid Disposal

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- Providing patients undergoing surgical procedures with an activated charcoal bag for opioid deactivation could increase appropriate opioid disposal, according to a research letter published online March 27 in JAMA Surgery.

Read More

Cimzia Injection Approved for New Inflammatory Arthritis Indication

THURSDAY, March 28, 2019 (Pharmacist's Briefing) -- Cimzia (certolizumab pegol) injection has been approved to treat adults with nonradiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation, the U.S. Food and Drug Administration announced.

Read More

Many Eligible Patients Report Not Being Offered Statins

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- More than half of patients eligible for statin therapy but not being treated report never being offered a statin, according to a study published online March 27 in the Journal of the American Heart Association.

Read More

Higher Disease Burden for OA Than RA After Six Months

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- After six months, osteoarthritis (OA) is associated with higher mean disease burden than rheumatoid arthritis (RA), according to a study published online March 20 in Arthritis & Rheumatology.

Read More

Adding Transition Services Does Not Aid Heart Failure Outcomes

WEDNESDAY, March 27, 2019 (Pharmacist's Briefing) -- Additional transitional care services do not improve outcomes for heart failure patients discharged from the hospital, according to a study recently published in the Journal of the American Medical Association.

Read More

$775 Million Settlement Reached in Xarelto Lawsuits

TUESDAY, March 26, 2019 (Pharmacist's Briefing) -- A settlement of $775 million will be paid to settle lawsuits involving the blood thinner Xarelto, Johnson & Johnson and Bayer said Monday.

Read More

U.S. Measles Cases Hit 314 This Year

TUESDAY, March 26, 2019 (Pharmacist's Briefing) -- There have been at least 314 reported cases of measles in the United States so far this year, according to new government data.

Read More

Recommendations Issued for Treating Osteoporosis

TUESDAY, March 26, 2019 (Pharmacist's Briefing) -- Recommendations have been developed for the pharmacological management of osteoporosis in postmenopausal women; the clinical practice guideline was published online March 25 in the Journal of Clinical Endocrinology & Metabolism to coincide with the annual meeting of The Endocrine Society, held from March 23 to 26 in New Orleans.

Read More

Mumps Outbreak at Temple University Reaches 74 Cases

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- A mumps outbreak that began last month at Temple University in Philadelphia has reached 15 confirmed and 59 probable cases.

Read More

Diabetes Underestimated With HbA1c Criteria

MONDAY, March 25, 2019 (Pharmacist's Briefing) -- The prevalence of diabetes mellitus (DM) is underestimated and normal glucose tolerance (NGT) is overestimated using hemoglobin A1c (A1c) criteria, according to a study presented at the annual meeting of The Endocrine Society, held from March 23 to 26 in New Orleans.

Read More

Copyright © 2019 HealthDay. All rights reserved.